Alex Spyropoulos

42PUBLICATIONS
107CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 16, 2026
Factor XI and XIa Inhibitors: A State-of-the-Art Review Across Clinical Indications.

|Feb 13, 2025
Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures.

Mark Goldin, Nikolaos Tsaftaridis, Jack Jnani

|Jan 21, 2025
Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study.

Joseph R Shaw, Na Li, Matthieu Grussé

|May 14, 2024
Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors.

Mark Goldin, Kolton Smith, Ioannis Koulas

|Apr 13, 2024
System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support.

Nikolaos Tsaftaridis, Mark Goldin, Alex C Spyropoulos

|Nov 23, 2023
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.

Judith Hsia, Alex C Spyropoulos, Gregory Piazza

Pageof 7

Frequent Collaborators

7 joint publications

Elliot S Barnathan

6 joint publications

Sam Schulman

5 joint publications

Beverley J Hunt

5 joint publications

Dimitrios Giannis